Tonix Pharmaceuticals To Present Study Involving TNX-1500 At The American Transplant Congress 2024
Portfolio Pulse from Benzinga Newsdesk
Tonix Pharmaceuticals Holding Corp. (NASDAQ:TNXP) will present a study involving TNX-1500 at the American Transplant Congress 2024. The company will have two oral presentations and a poster presentation at the event, which will be held from June 1-5, 2024, in Philadelphia.
May 29, 2024 | 12:04 pm
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
Tonix Pharmaceuticals will present a study on TNX-1500 at the American Transplant Congress 2024, which could increase visibility and interest in their pipeline.
Presenting at a major congress can increase visibility and credibility for Tonix Pharmaceuticals, potentially attracting investor interest and positively impacting the stock price in the short term.
CONFIDENCE 90
IMPORTANCE 70
RELEVANCE 100